knowledge -WSS

knowledge

author：leisure time 2025-10-02 23:47:36 - browse：71

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Akero's treatment for NASH falls short in cirrhosis study

entertainment

WSS

There’s no way to know how good AI health technologies are

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Histogen: Failed biotech offers rare public look inside

Medicare to cover more brain scans related to Alzheimer’s drugs

European regulators recommend Amylyx's ALS drug be rejected

Senate panel eyes new effort on drug shortages

Wikipedia

knowledge

leisure time

Drug repurposing or repositioning? The language matters

Bristol 'take

Malaria cases in Florida and Texas: Here’s what you need to know

Wellcome Trust names Røttingen as its new CEO

Dobbs anniversary: the lost opportunity of abortion as health care

Stroke deaths set to near 10 million globally by 2050

Activists slam private health insurers over coverage restrictions

European regulators recommend Amylyx's ALS drug be rejected

DIEP, the 'gold standard' of breast reconstruction, is under threat

Peter Marks talks Operation Warp Speed for Rare Diseases

hotspot

Physician executives need more than on

STAT Readout Newsletter: Today in biotech, life science news

Bill would stop addiction treatment from triggering child abuse inquiry

Readout LOUD podcast: Merger Mondays, Ozempic panic

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Akero's treatment for NASH falls short in cirrhosis study

hotspot

entertainment

entertainment

focus